throbber
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`
`CONOPCO INC. dba UNILEVER
`Petitioner
`v.
`THE PROCTOR & GAMBLE COMPANY
`Patent Owner
`
`U.S. Patent No. 6,649,155 to Dunlop et al.
`Issue Date: November 18, 2003
`Title: Anti-Dandruff and Conditioning Shampoos Containing
`Certain Cationic Polymers
`
`_____________________
`
`Inter Partes Review No. Unassigned
`_____________________
`
`
`Petition for Inter Partes Review of U.S. Patent No. 6,649,155 Under 35 U.S.C.
`§§ 311-319 and 37 C.F.R. §§ 42.1-.80, 42.100-.123
`
`
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`C.
`
`E.
`
`TABLE OF CONTENTS
`I.
`INTRODUCTION .......................................................................................... 1
`
`II.
`OVERVIEW ................................................................................................... 1
`
` GROUNDS FOR STANDING (37 C.F.R. § 42.104(a)); PROCEDURAL III.
`
`STATEMENTS ......................................................................................................... 1
`
` MANDATORY NOTICES (37 C.F.R. § 42.8(a)(1)) ..................................... 2 IV.
`STATEMENT OF THE PRECISE RELIEF REQUESTED AND THE
`V.
`
`REASONS THEREFOR (37 C.F.R. § 42.22(a)) ...................................................... 3
`
` CLAIM CONSTRUCTION ........................................................................... 3 VI.
`
` PERSON OF SKILL IN THE ART & STATE OF THE ART ...................... 5 VII.
`
` Identification of Challenge (37 C.F.R. § 42.104(b)) .................................... 13 VIII.
`A. Ground 1: Cothran anticipates claims 1-11, 19, and 20. .....................13
`B.
`Ground 2: Claims 1, 4-11, 19, and 20 would have been
`obvious to a POSA over Cothran and Sime. .......................................26
`Ground 3: Claims 2-3 and 12-18 would have been obvious
`over Cothran in view of Evans. ...........................................................32
`D. Ground 4: Claims 21-23 would have been obvious over
`Cothran in view of Bar-Shalom. .........................................................40
`Grounds 5-7: Claims 1-23 would have been obvious over the
`combinations of Cothran and Sime, Evans, or Bar-Shalom,
`in further view of Cosmedia. ...............................................................43
`Ground 8: Uchiyama anticipates claims 2-3 and 12-18. .....................45
`F.
`G. Ground 9: Claims 2-3 and 12-18 would have been obvious
`over Uchiyama. ...................................................................................54
`
` Objective Indicia of Nonobviousness ........................................................... 57 IX.
`Conclusion .................................................................................................... 60
`X.
`
`CERTIFICATION OF SERVICE (37 C.F.R. §§ 42.6(e), 42.105(a)) ...................... 1
`
`
`
`
`
`
`
`
`ii
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`
`
`I.
`
`
`INTRODUCTION
`
`Conopco, Inc. seeks cancellation of claims 1-23 of U.S. Pat. No. 6,649,155
`
`(EX 1001), which is owned by the Proctor & Gamble Company ("P&G").
`
` OVERVIEW II.
`
`
`The challenged claims of the '155 patent are unpatentable over the prior art.
`
`Because Conopco is, at a minimum, reasonably likely to prevail in showing
`
`unpatentability, trial should be instituted on all of the challenged claims.
`
`The shampoo compositions recited in the '155 patent claims (comprising an
`
`anionic surfactant, non-volatile conditioning agent, anti-dandruff particulate, and
`
`cationic guar derivative with a molecular weight 50,000 to 700,000 and charge
`
`density 0.05 to 1.0 meq/g, each in a specified percent amount) are simply an
`
`obvious reformulation of known shampoo compositions containing known
`
`components in known amounts. And the ‘155 patent’s claimed methods also would
`
`have been obvious prior to the patent's earliest possible priority date ("EPD").
`
` GROUNDS FOR STANDING (37 C.F.R. § 42.104(a)); PROCEDURAL III.
`
`
`STATEMENTS
`Conopco certifies that (1) the '155 patent is available for IPR and (2)
`
`Conopco is not barred or estopped from requesting IPR of any claim of the '155
`
`patent. This Petition is filed in accordance with 37 CFR § 42.106(a). Concurrently
`
`filed herewith is a Power of Attorney and an Exhibit List per § 42.10(b) and
`
`
`
`1
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`§ 42.63(e), respectively. The required fee is paid via online credit card payment.
`
`The Office is authorized to charge fee deficiencies and credit overpayments to
`
`Deposit Acct. No. 19-0036 (Customer ID No. 45324).
`
` MANDATORY NOTICES (37 C.F.R. § 42.8(a)(1)) IV.
`
`
`Each Real Party-In-Interest (37 C.F.R. § 42.8(b)(1)): CONOPCO, INC. DBA
`
`UNILEVER; UNILEVER, PLC; UNILEVER NV.
`
`Notice of Related Matters (37 C.F.R. § 42.8(b)(2)): Judicial matters:
`
`Procter & Gamble Co. v. Conopco Inc., 13-cv-00732, U.S. District Court,
`
`Southern District of Ohio. Administrative matters: Cases IPR2013-00505 and
`
`IPR2014-00506 for U.S. Pat. No. 6,974,569; Cases IPR2013-00509 and2014-
`
`00507 for U.S. Pat. No. 6,451,300. The '569 patent and '300 patent each issued
`
`from a distinct application having overlapping inventors and claiming priority to
`
`distinct applications filed on the same day as the provisional application to which
`
`the '155 patent claims priority. Trial was previously denied in case IPR2013-00510
`
`for the '155 patent based on grounds other than those presented below.
`
`Designation of Lead and Back-Up Counsel (37 C.F.R. § 42.8(b)(3)):
`
`Lead Counsel
`Eldora L. Ellison (Reg. No. 39,967)
`STERNE, KESSLER, GOLDSTEIN & FOX
`P.L.L.C.
`1100 New York Avenue, NW
`Washington, DC 20005
`202.772.8508 (telephone)
`
`Back-Up Counsel
`Robert Greene Sterne (Reg. No. 28,912)
`STERNE, KESSLER, GOLDSTEIN & FOX
`P.L.L.C.
`1100 New York Avenue, NW
`Washington, DC 20005
`202.772.8555 (telephone)
`
`
`
`2
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`Back-Up Counsel
`Lead Counsel
`202.371.2540 (facsimile)
`202.371.2540 (facsimile)
`rsterne-PTAB@skgf.com
`eellison-PTAB@skgf.com
`Notice of Service Information (37 C.F.R. § 42.8(b)(4)): Please direct all
`
`correspondence to lead counsel at the above address. Petitioner consents to email
`
`service at: eellison-PTAB@skgf.com and rsterne-PTAB@skgf.com.
`
`V.
`
`
`STATEMENT OF THE PRECISE RELIEF REQUESTED AND THE
`REASONS THEREFOR (37 C.F.R. § 42.22(a))
`
`Conopco requests IPR and cancellation of claims 1-23. Conopco's full
`
`statement of the reasons for the relief requested is set forth in § VIII below. In
`
`support of the proposed grounds for unpatentability, this Petition is accompanied
`
`by a declaration of technical expert Mr. Arun Nandagiri, which explains the
`
`meaning of claim terms, the state of the art and what the art would have conveyed
`
`to a POSA. EX 1043, e.g., ¶¶17-30. Mr. Nandagiri is qualified as an expert based
`
`on more than 30 years' experience in the shampoo industry supervising the
`
`formulation of shampoos and conditioners. EX 1043 ¶5-11.
`
` CLAIM CONSTRUCTION VI.
`
`
`The broadest reasonable interpretation ("BRI") for the claim term "cationic
`
`guar derivative" encompasses a cationic derivative of a guar gum and a cationic
`
`derivative of a polygalactomannan guar gum. A POSA understood that the terms
`
`
`
`3
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`guar gum and polygalctomannan guar gum were interchangeable. EX 1044, 22:27-
`
`29; EX 1028, 2:53-57; EX 1043, ¶18.1
`
`The BRI for the claim term "anti-dandruff particulate is a zinc salt of 1-
`
`hydroxy-2-pyridinethione" encompasses "zinc pyrithione." The '155 patent states
`
`that the preferred anti-dandruff agent is the zinc salt of 1-hydroxy-2-
`
`pyridinethione, which is "known as 'zinc pyridinethione' or 'ZPT'." EX 1001,
`
`17:17-24. The Example formulations use the term "zinc pyrithione" and state in a
`
`footnote "ZPT having an average particle size of 2.5 μm." EX 1001, 33:35-47, fn.
`
`3. When referring to the anti-dandruff agent later in the '155 patent, the term "zinc
`
`pyrithione" is used. EX 1001, 28:11-13. Thus, as confirmed by Mr. Nandagiri, the
`
`'155 patent uses the terms "zinc salt of 1-hydroxy-2-pyridinethione," "ZPT," and
`
`"zinc pyrithione" as all referring to the same chemical compound. EX 1043, ¶19.
`
`A POSA would have understood that: (i) the claimed shampoo compositions
`
`may include components in addition to those explicitly required and (ii) the claims
`
`do not require any particular level of effectiveness of the claimed shampoo
`
`
`1 For exhibits that are PCT publications, citations are to page numbers that
`
`Conopco added to the bottom of each page, starting with the face page. For all
`
`exhibits except the expert declaration, citations to paragraph numbers are for all
`
`paragraphs on a page, including both full and partial paragraphs.
`
`
`
`4
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`compositions (e.g., surfactant, antidandruff, or conditioning effectiveness). EX
`
`1043, ¶17-20.
`
`All other terms of all challenged claims are presumed to take on their
`
`ordinary and customary meanings. Conopco reserves its right to propose a different
`
`claim construction in a different forum, such as in district court where a different
`
`claim construction standard is used. Additionally, Conopco reserves its right to
`
`raise any and all invalidity defenses in district court, including indefiniteness under
`
`Section 112.
`
` PERSON OF SKILL IN THE ART & STATE OF THE ART VII.
`
`
`POSA: A person of ordinary skill in the art ("POSA") is a hypothetical
`
`person who is presumed to be aware of all pertinent art, thinks along conventional
`
`wisdom in the art, and is a person of ordinary creativity. A person of ordinary skill
`
`in the art of antidandruff and conditioning shampoos would have had knowledge of
`
`the scientific literature concerning use of surfactants and conditioners as of May 3,
`
`1999. A POSA as of May 3, 1999, would typically have (i) a Ph.D. or M.S. degree
`
`in pharmacy, physical chemistry (or a related field) with at least 2 years of
`
`experience in the development of shampoo formulations or (ii) a B.S. in pharmacy,
`
`physical chemistry (or a related field) with significant practical experience (4 or
`
`more years) in the development of shampoo formulations. A POSA may work as
`
`part of a multi-disciplinary team and draw upon not only his or her own skills, but
`
`
`
`5
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`also take advantage of certain specialized skills of others in the team, to solve a
`
`given problem. For example, a formulator having significant practical experience
`
`in the development of antidandruff and conditioning shampoos, a colloidal chemist
`
`and a surfactant specialist can be part of the team. EX 1043, ¶13.
`
`State of the Art: As is discussed below, the state of the art in formulating
`
`shampoos and conditioners was advanced before the EPD of May 3, 1999. The
`
`ingredients and their functions in these formulations were well known. Likewise,
`
`the amounts needed to obtain these functions were well known. EX 1043, ¶22-48.
`
`Consumer demand influenced shampoo and conditioner formulation.
`
`Consumers, before May 3, 1999, desired clean hair that was shiny, easily
`
`combable, and that lacked “fly away” (static). Shampoos and conditioning agents
`
`imparted these attributes to hair. Shampoos removed sebaceous oil (produced by
`
`the scalp) and other soils, such as the cationic polymers contained in hair products,
`
`from hair and scalp. EX 1045, 3:¶2; EX 1047, 33:¶1, 40:¶6 to 41:¶1; 45:¶1; EX
`
`1054, 123:¶3 “Soils From Hair Preparations”, 124:¶2; EX 1054, 123. But
`
`shampoos often left hair dry, dull, hard to comb, and full of static. EX 1042, 1:8-
`
`15. Conditioners added moisture, improved shine and combability, and reduced
`
`static. EX 1042, 1:15-31; EX 1047, 45:¶1. EX 1042, 1:8-46; EX 1049, 2-4; EX
`
`1040, item 5; EX 1045, 3:31 to 4:2.
`
`
`
`6
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`Because consumers preferred different levels of cleansing, conditioning, and
`
`other attributes (based in part on hair type), manufacturers recognized well before
`
`the EPD that they should offer shampoos and conditioners providing different
`
`levels of these attributes. EX 1047, 35:¶1, 45:¶4; EX 1047, 36:¶2-3. For example,
`
`formulations were made for, e.g., normal, dry, oily, damaged, grey, and fine hair,
`
`and for hair with dandruff. EX 1032, 85-86:Sect. IV.A.:item 5; EX 1032, 73:¶3;
`
`EX 1047, 34:¶1, 35:¶1, 43:¶4. As examples of different levels of conditioning,
`
`some consumers (e.g., those with dry hair) desired more conditioning, while others
`
`(e.g., those with oily or fine hair) wanted less. EX 1032, 73:¶3; EX 1047, 34:¶1,
`
`35:¶1, 43:¶4. Hence, formulators commonly factored in hair type when producing
`
`new compositions. EX 1032, 85-86:Sect. IV.A.
`
`And, in general, a POSA avoided over-conditioning because the result was a
`
`feeling that the hair was soiled. EX 1044, 4:6-7 (“undesirable, slimy feel”); EX
`
`1045, 4:3-6 (“Many of these [conditioning] actives have the disadvantage of
`
`leaving the hair feeling soiled or coated. . . . ”); 1047, 45:¶4 (Other problems have
`
`been some purported incidents of ‘overconditioning’ for some hair types.”); EX
`
`1028, 1:64 to 2:6 (“such deposition of substantial amounts of cationic polymer is
`
`not always desired by the user. . . “).
`
`A POSA therefore would have varied the components of antidandruff (AD)
`
`conditioning shampoos, such as the amount and types of cleansing, AD, and
`
`
`
`7
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`conditioning agents, as part of a process for routinely optimizing compositions for,
`
`e.g., cleansing, AD, and conditioning efficacy. EX 1010, ¶3; EX 1028, 5:19-28,
`
`5:50-56; EX 1044, 27:14-20; EX 1032, 96:Formulating Prototypes to 98:¶2; EX
`
`1041, 4:¶3; EX 1047, 45:¶2-4, 49:¶3 to 51:¶3, 54:¶1 (following the chemical
`
`structure); EX 1001, 32:4-17.
`
`Conditioning shampoos were known. Shampoos having good conditioning
`
`properties were known before the EPD and were favored by consumers who
`
`wanted the convenience of using a single composition for cleaning and
`
`conditioning, rather than two separate compositions. EX 1010, 3:¶2; EX 1044,
`
`2:11-21; EX 1043, ¶27-44; EX 1045, 3:31 to 4:2; EX 1001, 1:37-49. A POSA also
`
`knew that the conditioning effect of a conditioning shampoo depended on the type
`
`and amount of conditioning agent in the formulation. EX 1028, 1:57 to 2:23, 2:43-
`
`55; EX 1045, 4:3-15.
`
`It was known, for example, that cationic polymers such as cationic guar
`
`derivatives are conditioning agents in two respects: they are deposited onto hair as
`
`conditioning agents on their own, and they help deposit other conditioning agents
`
`(such as silicones) onto the hair to contribute to a conditioned feel. EX 1032, 68:¶5
`
`to 69:¶1; EX 1054, 141:5-6. A POSA also knew that the deposition (and thus
`
`conditioning effect) of cationic guar derivatives depended on their charge density
`
`(CD) and molecular weight (MW), as the ‘155 patent acknowledges. EX 1001,
`
`
`
`8
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`18:25-41; EX 1028, 4:47-54; EX 1032, 75:¶2 & 6, 76:3, 97:¶5; EX 1055, 201:¶4 &
`
`6, 206:¶5; EX 1054, 140:¶5 to 141:¶1. Thus, it was known that cationic guar
`
`derivatives having a relatively low CD did not deposit onto hair to the same extent
`
`as those having a higher CD. Id. (especially EX 1028, 4:47-54; EX 1032, 75:¶2).
`
`Likewise, it was known that cationic guar derivatives having a relatively low MW
`
`did not deposit onto hair as much as those with a higher MW. Id. (especially EX
`
`1055, 201:¶6).
`
`It was also known that the deposition onto hair of cationic polymers was
`
`increased in compositions containing anionic surfactants due to the formation of
`
`complexes (coacervates) between the polymer and the surfactant. EX 1055, 205:2;
`
`EX 1028, 1:57-64; EX 1001, 18:25-53. Formation of these complexes was known
`
`to be the result of the positive-negative charge attraction between these two
`
`molecule types. EX 1028, 1:37-57.
`
`Antidandruff, conditioning shampoos were known. Antidandruff (AD),
`
`conditioning shampoos also fulfilled consumer demand for at least 10 years before
`
`the EPD, as shown by, for example, Cothran (EX 1044), Evans (EX 1010), Sime
`
`(1028), Uchiyama (1045), Kalla (1041), and Reid (EX 1018), e.g., EX 1028, 6:11-
`
`23; EX 1018, 5:10-15; EX 1001, 1:30-48. These shampoos contained AD agents,
`
`such as ZPT, that were known to have antifungal activity. EX 1028, 6:11-23; EX
`
`1001, 1:30-48; EX 1051, title & abstract.
`
`
`
`9
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`Ingredients of AD conditioning shampoos, their amounts, and their
`
`functions were known in the art. A POSA would have known which components
`
`of shampoos acted as surfactants (cleansers and foaming agents), conditioning
`
`agents, AD agents, antimicrobial and antifungal agents, suspending agents (for
`
`keeping water-insoluble ingredients like conditioning and AD agents in suspension
`
`before use), spreading agents, shine-enhancing agents, deposition agents
`
`(depositing AD and conditioning agents onto hair and scalp), and thickening
`
`agents. EX 1043, ¶31-37.
`
`For example, many types of surfactant were known, including anionic
`
`surfactants. EX 1044, 6-10; EX 1045, 5-8. Nonvolatile silicones were known to act
`
`as conditioners. EX 1045, 15:4-19. As discussed above, ZPT was known to be an
`
`AD and antifungal agent. Ethylene glycol distearate and ethylene glycol
`
`monostearate were known to suspend other shampoo ingredients. EX 1010, 23:¶2-
`
`3. Polyalkylene glycols were known to improve lather and increase the
`
`spreadability of other shampoo components. EX 1010, 1: title & abstract, 21:¶4;
`
`EX 1043, ¶31, 32. High-refractive-index, non-volatile silicones were known to
`
`enhance shine, especially when used with spreading agents. EX 1044, 17:22-28;
`
`EX 1043, ¶33.
`
`In addition to being conditioning and deposition agents, cationic polymers
`
`such as cationic guar derivatives and cationic cellulose derivatives (e.g.,
`
`
`
`10
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`polyquaternium-10) were known to be suspending (including suspension
`
`stabilizing) and thickening agents. EX 1044, 19:10-20, 22:1-34; EX 1032,
`
`74:“Cationic Polymers”, 75:¶4, 76:¶3. And, as deposition agents, they were known
`
`to deposit insoluble shampoo components like AD agents and conditioning silicone
`
`onto hair and scalp. EX 1028, 1:7-15, 5:19-25; EX 1041, 3:¶3 & 5 to 4:¶1; EX
`
`1043, ¶35-37.
`
`Useful concentration ranges of these components in AD, conditioning
`
`shampoos and processes of formulating such shampoos were also well known
`
`before the EPD. EX 1043, ¶26-38. Cothran, Evans, and Uchiyama, for example,
`
`disclose AD conditioning shampoos and show a wide range of component amounts
`
`that were effective. EX 1044, 19:10-15, 27:814-20, 36:claims 1-3; 29:¶2, 34:claims
`
`1-4; EX 1045, 27:9-13, 31-32:claims 1-2; EX 1043, ¶35-37. They also disclose
`
`that cationic guar derivatives having a wide range of MWs and CDs were effective
`
`as conditioning, stabilizing, and deposition agents, as is discussed below. EX 1044,
`
`19:25-36, 22:27-29; EX 1045, 20:25-32, 23:1-3; EX 1010, 6:¶1-2, 27:¶2.
`
`Cationic guar derivatives with MWs of about 2,000 to about 3,000,000
`
`and CDs of about 0.1 meq/g to about 4.0 meq/g were known for use in
`
`shampoos. EX 1043, ¶38-39. Cationic guar derivatives with MWs of about 2,000
`
`to about 3,000,000 and CDs of about 0.1 meq/g to about 4.0 meq/g were known for
`
`use in shampoos before the EPD. EX 1044, 19:25-36, 22:27-29; EX 1045, 20:25-
`
`
`
`11
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`32, 23:1-3; EX 1010, 6:¶1-2, 27:¶2; EX 1041, 16:¶2-3; EX 1028, 2:13-22, 2:39-42,
`
`2:53-55. Cationic guars having these MWs and CDs also were commercially
`
`available. For example, guar hydroxylpropyl trimonium chloride (e.g., Cosmedia®
`
`Guar C 261) was available and had a MW of about 220,000 and a CD of 0.4
`
`meq/g. EX1040, items 1 & 6; EX 1053, 3:30-43; EX 1043, 38, 146-150. Likewise,
`
`a cationic guar having MW of about 200,000 and CD of 0.71 meq/g was available
`
`from Aqualon before the EPD. EX 1001, 33:33-34, 33:43-45; EX 1043, ¶38-39.
`
`Making and testing AD conditioning shampoos was routine. Making and
`
`testing AD conditioning shampoo compositions was routine. EX 1028, 4:54-65,
`
`5:45-55, 6:36 to 7:17; EX 1032, 96:last ¶ to 97:¶3. As discussed above, consumer
`
`preferences and routine optimization each would have led a POSA to decrease or
`
`increase the amount, or change the type, of conditioning and other agents in
`
`shampoos. EX 1043, ¶42-44. Making and testing these varied formulations was
`
`routine by May 3, 1999. EX 1028, 4:54-65, 5:45-55, 6:36 to 7:17; EX 1032,
`
`96:last ¶ to 97:¶3. And a POSA would have had a reasonable expectation of being
`
`able to successfully produce a shampoo having cleansing, antidandruff, and
`
`conditioning efficacy. EX 1028, 4:54-65, 5:45-55, 6:36 to 7:17; EX 1032, 96:last ¶
`
`to 97:¶3; EX 1043, ¶45-53.
`
`
`
`12
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`
` Identification of Challenge (37 C.F.R. § 42.104(b)) VIII.
`IPR is requested on the grounds listed in the index below. Per 37 C.F.R.
`
`§ 42.6(d), copies of the references are filed herewith.
`
`Ground Pre-AIA
`35 U.S.C.
`§102(b)
`§103
`§103
`§103
`§103
`§103
`
`1
`2
`3
`4
`5
`6
`
`7
`
`8
`9
`
`
`
`§103
`
`§102(b)
`§103
`
`Index of Reference(s)
`
`'155 patent claims
`
`Cothran
`Cothran and Sime
`Cothran and Evans
`Cothran and Bar-Shalom
`Cothran and Cosmedia
`Cothran, Cosmedia, and
`Evans
`Cothran, Cosmedia, and
`Bar-Shalom
`Uchiyama
`Uchiyama
`
`1-11, 19, and 20
`1, 4-11, 19, and 20
`2-3 and 12-18
`21-23
`1, 4-11, 19, and 20
`2-3 and 12-18
`
`21-23
`
`2-3 and 12-18
`2-3 and 12-18
`
`Cothran and Uchiyama each disclose every element of the claims noted
`
`above for §102(b), arranged as claimed, and enabled to a POSA, in light of the
`
`general knowledge in the art. And the prior art references listed above for §103
`
`render obvious the noted claims. Mr. Nandagiri's declaration provides a thorough
`
`discussion of the state of the art at the time of this alleged "invention." EX 1043,
`
`¶¶22-61. All of the claims lack patentability.
`
`A. Ground 1: Cothran anticipates claims 1-11, 19, and 20.
`Cothran (EX 1044) anticipates claims 1-11, 19, and 20. Cothran is prior art
`
`to the '155 patent under 35 U.S.C. §102(b). EX 1044; EX 1043, § XI.
`
`
`
`13
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`Cothran claims and discloses the shampoo compositions of claims 1 and
`
`19:
`
`'155 patent claims
`1. A shampoo
`19. A shampoo
`composition
`composition
`comprising:
`comprising:
`a) from about
`a) from about
`5% to about
`10% to about
`50%, by weight
`25%, by weight
`of the
`of the
`composition, of
`composition, of
`an anionic
`an anionic
`surfactant;
`surfactant;
`
`b) from about
`0.01% to about
`10%, by weight
`of the
`composition, of a
`non-volatile
`conditioning
`agent;
`
`b) from about
`0.01% to about
`10%, by weight
`of the
`composition, of
`an insoluble,
`non-volatile
`silicone
`conditioning
`agent;
`
`c) from about
`c) from about
`
`2 Bold text is added emphases.
`
`Cothran’s (EX 1044) Disclosure
`Claim 1 of Cothran recites: "1. A conditioning
`shampoo2 composition comprising . . . ." (EX
`1044, 36:claim 1 preamble.)
`Claim 1 of Cothran recites: "1. A conditioning
`shampoo composition comprising . . . (a)
`from 8% to 40%, by weight, of detersive
`surfactant, said composition containing at
`least 5%, by weight, of anionic detersive
`surfactant” (EX 1044, 36:claim 1 preamble,
`claim 1(a).)
`
`Claim 5 of Cothran depends from all preceding
`claims and recites "8-25%, by weight," of
`anionic surfactant. (EX 1044, 36:claim 5.)
`Claim 1 of Cothran recites: "1. A conditioning
`shampoo composition comprising . . . (b)
`from 0.05% to 5%, by weight, of an insoluble
`silicone conditioning agent, said conditioning
`agent being the form of dispersed droplets of
`insoluble silicone . . .” (EX 1044, 36:claim
`1(b).)
`Claim 3 of Cothran recites: “wherein said
`insoluble silicone conditioning agent is
`polydimethylsiloxane.” (EX 1044, 36:claim
`3.)
`Cothran states: “The silicone conditioning
`agent will preferably be nonvolatile. The term
`‘nonvolatile’ as used herein shall mean that the
`material has a boiling point of at least about
`260°C . . .” (EX 1044, 16:9-12.)
`Cothran states: "Particulate antidandruff
`
`
`
`14
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`'155 patent claims
`0.1% to about
`0.3% to about
`4%, by weight
`2%, by weight
`of the
`of the
`composition, of
`composition, of a
`an anti-dandruff
`zinc salt of 1-
`particulate;
`hydroxy-2-
`pyridinethione;
`
`d) from about
`0.02% to about
`5%, by weight
`of the
`composition, of a
`cationic guar
`derivative;
`
`d) from about
`0.1% to about
`5%, by weight
`of the
`composition, of a
`cationic guar
`derivative,
`
`i) wherein said
`cationic guar
`derivative has a
`molecular
`weight from
`about 50,000 to
`about 700,000;
`and
`ii) wherein said
`cationic guar
`derivative has a
`charge density
`from about 0.05
`meq/g to about
`
`i) wherein said
`cationic guar
`derivative has a
`molecular weight
`from about
`100,000 to about
`400,000; and
`ii) wherein said
`cationic guar
`derivative has a
`charge density
`from about 0.4
`meq/g to about
`1.0 meq/g;
`
`Cothran’s (EX 1044) Disclosure
`agents include, for example, . . . pyridinethione
`salts. Preferred are heavy metal salts of 1-
`hydroxy-2-pyridinethione and selenium
`disulfide. . . . In general, particulate
`antidandruff agents can be present at levels
`of about 0.1% to about 5%, preferably from
`about 0.3% to about 2%, by weight of the
`composition." (EX 1044, 28:9-18.)
`Cothran states: “Preferred pyridinethione
`antidandruff agents are water insoluble 1-
`hydroxy-2-pyridinethione salts. . . .The most
`preferred active is the zinc salt of 1-hydroxy-
`2-pyridinethione, often referred to as zinc
`pyridinethione (ZPT).” (EX 1044, 28:9-14.)
`Claim 1 of Cothran recites: "1. A conditioning
`shampoo composition comprising . . . (c) from
`0.01% to 1%, by weight, of a stabilizing
`agent for said silicone conditioning agent, said
`stabilizing agent being a shampoo soluble
`cationic polymer . . .” (EX 1044, 36:1-9.)
`Cothran states: “Other cationic polymers
`that can be used include cationic guar gum
`derivatives, such as guar hydroxypropyl-
`trimonium chloride." (EX 1044, 22:27-28.)
`Claim 1 of Cothran recites: "1. A conditioning
`shampoo composition comprising . . . (c) from
`0.01% to 1%, by weight, of a stabilizing
`agent for said silicone conditioning agent, said
`stabilizing agent being a shampoo soluble
`cationic polymer . . ." (EX 1044, 36:claim
`1(c).)
`Claim 2 of Cothran recites: “2. A shampoo
`composition as in Claim 1, wherein said
`composition comprises at least 10%, by
`weight, of said detersive surfactant, and
`wherein said cationic polymer has a weight
`average molecular weight of at least 200,000
`and a charge density of at least 0.3 meq/g,
`
`
`
`15
`
`

`
`'155 patent claims
`1.0 meq/g;
`
`e) water.
`
`e) water.
`
`Petition for Inter Partes Review of USPN 6,649,155
`
`Cothran’s (EX 1044) Disclosure
`and further wherein said cationic polymer has
`a weight average molecular weight of from
`400,000 to 2,000,000 and a charge density of
`from 0.6 meq/g to 4 meq/g." (EX 1044,
`36:15-20.)
`Cothran states: “Other cationic polymers that
`can be used include cationic guar gum
`derivatives, such as guar hydroxypropyl-
`trimonium chloride." (EX 1044, 22:27-28.)
`
`Claim 1 of Cothran recites: "1. A conditioning
`shampoo composition comprising . . . (d) . . .
`water . . ." (EX 1044, 36:claim 1(d).)
`
`Cothran claims and discloses shampoo compositions having all of the
`
`components recited in claims 1 and 19. EX 1043, ¶68-78. As shown in the claim
`
`chart above, Cothran’s claim 5 (which depends from Cothran’s claim’s 1-4),
`
`coupled with Cothran’s specification, recites shampoos that meet all of the
`
`limitations of each of claims 1 and 19.
`
`Cothran’s claimed shampoos contain ingredients in amounts that overlap
`
`with or subsume each of the concentration ranges recited in claims 1 and 19 for the
`
`anionic surfactant, non-volatile conditioning agent, AD particulate, and cationic
`
`guar derivative. For example, the ‘155 patent’s claim 1 requires about 5 to about
`
`50% anionic surfactant. A POSA would have understood that the recitation in
`
`claim 1 of Cothran of “from 8% to 40%, by weight, of detersive surfactant, said
`
`composition containing at least 5%, by weight, of anionic detersive surfactant” to
`
`
`
`16
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`require “5 to 40% of anionic surfactant.” EX 1043, 71. Cothran’s claim 5 depends
`
`from Cothran’s claims 1-4 and requires 8% to 25% anionic detersive surfactant.
`
`And the cationic guar derivatives in Cothran's shampoo compositions have
`
`MW and CD ranges that overlap with each of claims 1 and 19. Regarding the MW
`
`in Cothran's claim 2 (for the generic “cationic polymer” of claim 1), a POSA
`
`immediately would have envisioned that the range of “at least 200,000” (for the
`
`generic category of cationic polymers), when applied to Cothran’s specification’s
`
`cationic guar derivatives, to have an upper limit of about 3,000,000. EX 1044,
`
`19:10-31 & 22:27-32; EX 1043, 73. This is so because a POSA knew that cationic
`
`guar derivatives are produced from natural guar, which was known to have a
`
`maximum MW of about 1,300,000. EX 1054, 132:Table 2. A POSA also knew that
`
`the addition of cationic groups to natural guar increases the MW to a maximum of
`
`about 3,000,000. EX 1043, 73; EX 1041, 16:¶3; 1028, 2:39-42 & 2:53-68. Thus,
`
`Cothran disclosed, to a POSA, a cationic guar derivative with a MW of 200,000 to
`
`about 3,000,000.
`
`A POSA also would have found Cothran’s disclosure to be enabling in light
`
`of general knowledge in the art, as methods of making shampoo compositions were
`
`well known, and only ordinary skill was needed to make such compositions. EX
`
`1043, 74. For example, preparing Cothran’s shampoo that anticipates claims 1 and
`
`19 merely involves conventional formulation techniques, which would have
`
`
`
`17
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`required only ordinary skill. EX 1043, 76. Indeed, the ‘155 patent’s shampoo
`
`compositions can be prepared using conventional methods, as the patent
`
`acknowledges. EX1 001, 32:4-17.
`
`The ranges for the ‘155 patent’s shampoo compositions are not critical
`
`or considerably different from those in Cothran. The ranges recited in claims 1
`
`and 19 are not critical or considerably different from Cothran’s ranges. EX 1043,
`
`75. It is "an elementary principle of patent law that when, as by a recitation of
`
`ranges or otherwise, a claim covers several compositions, the claim is 'anticipated'
`
`if one of them is in the prior art." Titanium Metals, 778 F.2d 775 at 782. And, in
`
`the absence of extenuating circumstances, a prior art range that overlaps or entirely
`
`subsumes a claimed range anticipates that claimed range. Id. To establish
`
`patentability, a patentee must show that the claimed range was "critical" or that
`
`there was a considerable difference between the range taught in the prior art and
`
`the claimed range. See ClearValue, Inc. v. Pearl River Polymers, 668 F.3d at 1344-
`
`45 (Fed. Cir. 2012).
`
`Here, claims 1 and 19 recite shampoo components in ranges overlapping
`
`with or subsumed by Cothran’s ranges, and each component functions in the same
`
`way that Cothran’s shampoo components function. EX 1044, 36:claims 1-4; EX
`
`1001, 34:45-59, 36:7-24. The claims do not require any particular level of
`
`cleansing, AD efficacy, or conditioning (or deposition) efficacy. Nor do they
`
`
`
`18
`
`

`
`Petition for Inter Partes Review of USPN 6,649,155
`
`require an improvement over Cothran’s shampoo compositions. EX 1043, ¶75-76.
`
`Thus, the claims do not include any limitation about which the recited ranges can
`
`be found to be critical or substantially different.
`
`P&G argued during prosecution that the recited guar's low molecular weight
`
`of about 50,000 to about 700,000 was "critical" for "creating a clean feeling of
`
`hair." EX 1002, 108-111. P&G’s evidence consisted of a “clean feel performance”
`
`comparison of two shampoos: the “prior art” shampoo, which con

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket